21 CFR Part 11 Compliance Software Checklist: 7 Must-Have Features Before You Buy

For pharmaceutical and medical device companies operating under FDA regulation, 21 CFR Part 11 is not optional, it is the regulatory backbone governing how electronic records and electronic signatures are created, managed, and stored. But many pharma companies can barely keep up with compliance, not because the firms do not want to put systems in place, but simply because they have no idea how to create them.

Accordingly, selecting the incorrect 21 CFR Part 11 compliance software solution increases your business risk of audit failures, FDA warning letters and expensive corrective action. This checklist outlines the 7 must-have features you need to evaluate before making your investment.

Why Pharma Companies Struggle with Compliance

Now, before getting to the checklist it is essential to know what lead to compliance failures. Most pharma companies struggle with compliance due to legacy systems that lack built-in audit capabilities, fragmented software tools with no centralized compliance framework, manual paper-based processes that are error-prone, and insufficient user access controls. Without purpose-built software, even well trained teams find themselves exposed during FDA inspections.

The solution is not just any software,it is the right software, validated and built for the specific demands of Part 11.

The 7-Feature Checklist for 21 CFR Part 11 Compliance Software

1. Automated and Tamper-Evident Audit Trails

Each action inside the system, whether creating a record, modifying it, deleting it or approving must be automatically logged with timestamp and user identity. The audit trail must be secure, unalterable, and quickly accessible by FDA inspectors. Any 21 CFR Part 11 compliance software that lacks a robust, automatic audit trail is a non-starter for regulated environments.

2. Electronic Signatures with Identity Binding

Part 11 requires the use of electronic signatures with unique linking to individual users that cannot be copied, transferred or repudiated. Your software must enforce signature meaning, clearly indicating whether a signature represents authorship, review, or approval. Find a system which requires re-entry of passwords at the moment of the signing and keeps a full signature manifest associated with each record.

3. Role-Based Access Controls (RBAC)

There is no need for every user in your organization to have access to all its functions. Your compliance solution should enforce role based, granular permissions that allow only authorized Quality to release materials, approve batch records and change critical data. RBAC is a direct requirement of Part 11 and your first line of defense against data integrity violations.

4. Data Integrity and Tamper-Evident Records

Your electronic records must meet the ALCOA+ standard: Attributable, Legible, Contemporaneous, Original, and Accurate. Users of the software should not be able to edit records once finalized; data must not be capable of being deleted or overwritten without a change event that is easily traceable. This is exactly where most pharma companies trip up on compliance when they solely rely on generic ERP systems or complex spreadsheets.

5. System Validation Support and Pre-Built Documentation

The FDA expects that any software used in a regulated environment is formally validated. Your vendor should provide a complete validation package including Installation Qualification (IQ), Operational Qualification (OQ), and Functional Requirement Specification (FRS) templates. This dramatically reduces your internal validation burden and accelerates implementation timelines.

6. Secure and Enforced User Authentication

Part 11 requires that system access be controlled through unique user IDs and strong authentication mechanisms. Your software should support enforced password policies, automatic session timeouts, and account lockouts after failed login attempts. Shared logins or generic accounts are a direct compliance violation and a common finding during FDA inspections.

7. Seamless Integration with ERP, LIMS, and QMS

Compliance does not exist in isolation. Your 21 CFR Part 11 compliance software must integrate seamlessly with your Enterprise Resource Planning (ERP), Laboratory Information Management System (LIMS), and Quality Management System (QMS). Disconnected systems create data silos and introduce compliance risk every time information is manually transferred between platforms.

Conclusion

Pharma companies struggle with compliance most often when they delay investing in the right infrastructure. Evaluating prospective vendors by this 7 features checklist ensures that your 21 CFR Part 11 compliance software isn't just a box-checker, but rather an operational investment which will serve both your data, your people and even the FDA for many years to come.

The cost of the wrong software is always higher than the cost of the right one.